386 related articles for article (PubMed ID: 24820890)
21. Biofilms in skin infections: Propionibacterium acnes and acne vulgaris.
Coenye T; Honraet K; Rossel B; Nelis HJ
Infect Disord Drug Targets; 2008 Sep; 8(3):156-9. PubMed ID: 18782032
[TBL] [Abstract][Full Text] [Related]
22. Sebum free fatty acids enhance the innate immune defense of human sebocytes by upregulating beta-defensin-2 expression.
Nakatsuji T; Kao MC; Zhang L; Zouboulis CC; Gallo RL; Huang CM
J Invest Dermatol; 2010 Apr; 130(4):985-94. PubMed ID: 20032992
[TBL] [Abstract][Full Text] [Related]
23. Isotretinoin increases skin-surface levels of neutrophil gelatinase-associated lipocalin in patients treated for severe acne.
Lumsden KR; Nelson AM; Dispenza MC; Gilliland KL; Cong Z; Zaenglein AL; Thiboutot DM
Br J Dermatol; 2011 Aug; 165(2):302-10. PubMed ID: 21466536
[TBL] [Abstract][Full Text] [Related]
24. Short-Chain Fatty Acids from
Sanford JA; O'Neill AM; Zouboulis CC; Gallo RL
J Immunol; 2019 Mar; 202(6):1767-1776. PubMed ID: 30737272
[TBL] [Abstract][Full Text] [Related]
25. Reactive oxygen species activated NLRP3 inflammasomes prime environment-induced murine dry eye.
Zheng Q; Ren Y; Reinach PS; She Y; Xiao B; Hua S; Qu J; Chen W
Exp Eye Res; 2014 Aug; 125():1-8. PubMed ID: 24836981
[TBL] [Abstract][Full Text] [Related]
26. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease.
Sugisaki H; Yamanaka K; Kakeda M; Kitagawa H; Tanaka K; Watanabe K; Gabazza EC; Kurokawa I; Mizutani H
J Dermatol Sci; 2009 Jul; 55(1):47-52. PubMed ID: 19375895
[TBL] [Abstract][Full Text] [Related]
27. Pathogenesis of acne.
Toyoda M; Morohashi M
Med Electron Microsc; 2001 Mar; 34(1):29-40. PubMed ID: 11479771
[TBL] [Abstract][Full Text] [Related]
28. Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes.
Nagy I; Pivarcsi A; Kis K; Koreck A; Bodai L; McDowell A; Seltmann H; Patrick S; Zouboulis CC; Kemény L
Microbes Infect; 2006 Jul; 8(8):2195-205. PubMed ID: 16797202
[TBL] [Abstract][Full Text] [Related]
29. Sebocytes contribute to skin inflammation by promoting the differentiation of T helper 17 cells.
Mattii M; Lovászi M; Garzorz N; Atenhan A; Quaranta M; Lauffer F; Konstantinow A; Küpper M; Zouboulis CC; Kemeny L; Eyerich K; Schmidt-Weber CB; Törőcsik D; Eyerich S
Br J Dermatol; 2018 Mar; 178(3):722-730. PubMed ID: 28799643
[TBL] [Abstract][Full Text] [Related]
30. Involvement of Propionibacterium acnes in the augmentation of lipogenesis in hamster sebaceous glands in vivo and in vitro.
Iinuma K; Sato T; Akimoto N; Noguchi N; Sasatsu M; Nishijima S; Kurokawa I; Ito A
J Invest Dermatol; 2009 Sep; 129(9):2113-9. PubMed ID: 19282842
[TBL] [Abstract][Full Text] [Related]
31. The Anti-Inflammatory Activities of Propionibacterium acnes CAMP Factor-Targeted Acne Vaccines.
Wang Y; Hata TR; Tong YL; Kao MS; Zouboulis CC; Gallo RL; Huang CM
J Invest Dermatol; 2018 Nov; 138(11):2355-2364. PubMed ID: 29964032
[TBL] [Abstract][Full Text] [Related]
32. TRPV3 promotes sebocyte inflammation via transcriptional modulating TLR2 in acne.
Wei Z; Gao M; Liu Y; Zeng R; Liu J; Sun S; Li S; Hu L; Xiang R; Mo R; Song Z; Chen Z; Bao D; Hua D; Zouboulis CC; Feng Y; Li J; Yang Y
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167195. PubMed ID: 38648901
[TBL] [Abstract][Full Text] [Related]
33. Propionibacterium acnes and acne.
Holland KT; Aldana O; Bojar RA; Cunliffe WJ; Eady EA; Holland DB; Ingham E; McGeown C; Till A; Walters C
Dermatology; 1998; 196(1):67-8. PubMed ID: 9557229
[No Abstract] [Full Text] [Related]
34. Activation of NLRP3 Inflammasome by Palmitic Acid in Human Sebocytes.
Jung YR; Shin JM; Kim CH; Kim S; Kim CD; Seo YJ; Lee JH; Im M; Lee Y; Lee YH
Ann Dermatol; 2021 Dec; 33(6):541-548. PubMed ID: 34858005
[TBL] [Abstract][Full Text] [Related]
35. Repurposing Auranofin, an Anti-Rheumatic Gold Compound, to Treat Acne Vulgaris by Targeting the NLRP3 Inflammasome.
Yang G; Lee SJ; Kang HC; Cho YY; Lee HS; Zouboulis CC; Han SH; Ma KH; Jang JK; Lee JY
Biomol Ther (Seoul); 2020 Sep; 28(5):437-442. PubMed ID: 32319265
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris.
Nakatsuji T; Kao MC; Fang JY; Zouboulis CC; Zhang L; Gallo RL; Huang CM
J Invest Dermatol; 2009 Oct; 129(10):2480-8. PubMed ID: 19387482
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effects of superoxide dismutase 3 on Propionibacterium acnes-induced skin inflammation.
Nguyen CT; Sah SK; Zouboulis CC; Kim TY
Sci Rep; 2018 Mar; 8(1):4024. PubMed ID: 29507345
[TBL] [Abstract][Full Text] [Related]
38. Incidence and lipolytic activity of Propionibacterium acnes (Corynebacterium acnes group I) and P. granulosum (C. acnes group II) in acne and in normal skin.
Whiteside JA; Voss JG
J Invest Dermatol; 1973 Feb; 60(2):94-7. PubMed ID: 4266325
[No Abstract] [Full Text] [Related]
39. On the propionibacteria in the pilosebaceous ducts of uninvolved skin of acne patients.
Gloor M; Franke M
Arch Dermatol Res; 1978 Jun; 262(1):125-9. PubMed ID: 150822
[TBL] [Abstract][Full Text] [Related]
40. What is new in the pathophysiology of acne, an overview.
Dréno B
J Eur Acad Dermatol Venereol; 2017 Sep; 31 Suppl 5():8-12. PubMed ID: 28805938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
